Quest Diagnostics Inc. Reports First Quarter 2014 Financial Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MADISON, N.J., April 24, 2014 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today that for the first quarter ended March 31, 2014, adjusted income from continuing operations was $122 million, or $0.84 per diluted share, compared to $143 million, or $0.89 per diluted share, for 2013. Reported income from continuing operations was $104 million, or $0.71 per diluted share, compared to $116 million, or $0.72 per diluted share, in 2013.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC